Evidence map›Paper›PMID 30870432›Full record

ArticlePLoS genetics2019

Blocking skeletal muscle DHPRs/Ryr1 prevents neuromuscular synapse loss in mutant mice deficient in type III Neuregulin 1 (CRD-Nrg1).

Yun Liu, Yoshie Sugiura, Fujun Chen, Kuo-Fen Lee, Qiaohong Ye, Weichun Lin

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. NMJ-related diseases beyond the congenital myasthenic syndromes.Frontiers in cell and developmental biology · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yun LiuDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, United States of America.
Yoshie SugiuraDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, United States of America.
Fujun ChenDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, United States of America.
Kuo-Fen LeeThe Salk Institute, La Jolla, United States of America.
Qiaohong YeDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, United States of America.
Weichun LinDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, United States of America.ORCID 0000-0002-6806-3329
Southwestern Medical Center · USSalk Institute for Biological Studies · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Reuben Shaw · 1985 to 2026
$82.8M
Molecular SignaturesU19MH114831 · NIMH · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI ECKER, JOSEPH R · 2017 to 2021
$24.6M
Patterning and Formation of the Neuromuscular JunctionR01NS055028 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI WEICHUN LIN, Beverly A Rothermel · 2007 to 2026
$9.9M
Physiology and function of basal ganglia subcircuits in sequence learningR01NS083815 · NINDS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI LEE, KUO-FEN · 2013 to 2022
$3.8M
Development of marmoset models of neurodegenerative disease using embryonic stem cell-based gene-editing approachesR24OD023076 · OD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI LEE, KUO-FEN, REYNOLDS, JOHN H · 2017 to 2020
$3.1M
Modeling Alzheimer's Disease Related Dementias in the MarmosetR61NS115183 · NINDS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI LEE, KUO-FEN · 2019 to 2019
$2.6M
Optogenetic dissection of brain network deficits in Alzheimer's DiseaseRF1AG047669 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI JIN, XIN, LEE, KUO-FEN · 2014 to 2015
$2.2M
NCI NIH HHS P30 CA014195NIA NIH HHS RF1 AG047669NIH HHS R24 OD023076NIMH NIH HHS U19 MH114831NINDS NIH HHS R01 NS055028NINDS NIH HHS R01 NS083815NINDS NIH HHS R61 NS115183
6 · The paper itself

Abstract

Schwann cells are integral components of vertebrate neuromuscular synapses; in their absence, pre-synaptic nerve terminals withdraw from post-synaptic muscles, leading to muscle denervation and synapse loss at the developing neuromuscular junction (NMJ). Here, we report a rescue of muscle denervation and neuromuscular synapses loss in type III Neuregulin 1 mutant mice (CRD-Nrg1-/-), which lack Schwann cells. We found that muscle denervation and neuromuscular synapse loss were prevented in CRD-Nrg1-/-mice when presynaptic activity was blocked by ablating a specific gene, such as Snap25 (synaptosomal-associated 25 kDa protein) or Chat (choline acetyltransferase). Further, these effects were mediated by a pathway that requires postsynaptic acetylcholine receptors (AChRs), because ablating Chrna1 (acetylcholine receptor α1 subunit), which encodes muscle-specific AChRs in CRD-Nrg1-/-mice also rescued muscle denervation. Moreover, genetically ablating muscle dihydropyridine receptor (DHPR) β1 subunit (Cacnb1) or ryanodine receptor 1 (Ryr1) also rescued muscle denervation and neuromuscular synapse loss in CRD-Nrg1-/-mice. Thus, these genetic manipulations follow a pathway-from presynaptic to postsynaptic, and, ultimately to muscle activity mediated by DHPRs and Ryr1. Importantly, electrophysiological analyses reveal robust synaptic activity in the rescued, Schwann-cell deficient NMJs in CRD-Nrg1-/-Cacnb1-/-or CRD-Nrg1-/-Ryr1-/-mutant mice. Thus, a blockade of synaptic activity, although sufficient, is not necessary to preserve NMJs that lack Schwann cells. Instead, a blockade of muscle activity mediated by DHRPs and Ryr1 is both necessary and sufficient for preserving NMJs that lack Schwann cells. These findings suggest that muscle activity mediated by DHPRs/Ryr1 may destabilize developing NMJs and that Schwann cells play crucial roles in counteracting such a destabilizing activity to preserve neuromuscular synapses during development.

Indexed as

AnimalsAxonsCalcium Channels, L-TypeElectrophysiologyHumansMiceMotor NeuronsMuscle DenervationMuscle, SkeletalNerve RegenerationNeuregulin-1Neuromuscular JunctionPresynaptic TerminalsReceptors, NicotinicRyanodine Receptor Calcium Release ChannelSchwann CellsCACNA1S protein, mouseCacnb1 protein, mouseCalcium Channels, L-TypeCHRNA1 protein, mouseNeuregulin-1Nrg1 protein, mouseReceptors, Nicotinicryanodine receptor 1, mouseRyanodine Receptor Calcium Release ChannelSnap25 protein, mouseSynaptosomal-Associated Protein 25

Identifiers

PMID30870432
PMCPMC6417856
OpenAlexW2921305587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.